Skip to main content

Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.

Publication ,  Journal Article
Voora, D; Shah, SH; Reed, CR; Zhai, J; Crosslin, DR; Messer, C; Salisbury, BA; Ginsburg, GS
Published in: Circ Cardiovasc Genet
December 2008

BACKGROUND: There is interindividual variation in low-density lipoprotein cholesterol (LDLc) lowering by statins and limited study into the genetic associations of the dose dependant LDLc lowering by statins. METHODS AND RESULTS: Five hundred nine patients with hyperlipidemia were randomly assigned atorvastatin 10 mg, simvastatin 20 mg, or pravastatin 10 mg (low-dose phase) followed by 80 mg, 80 mg, and 40 mg (high-dose phase), respectively. Thirty-one genes in statin, cholesterol, and lipoprotein metabolism were sequenced and 489 single nucleotide polymorphisms with minor allele frequencies >2% were tested for associations with percentage LDLc lowering at low doses using multivariable adjusted general linear regression. Significant associations from the analysis at low dose were then repeated at high-dose statins. At low doses, only 1 single nucleotide polymorphism met our experiment-wide significance level, ABCA1 rs12003906. Twenty-six subjects carried the minor allele of rs12003906, which was associated with an attenuated LDLc reduction (LDLc reduction in carriers versus noncarriers -24.1+/-2.6% versus -32.2+/-1.5%; P=0.0001). In addition, we replicated the association with the APOE epsilon3 allele and a reduced LDLc reduction. At high doses, carriers of the minor allele of ABCA1 rs12003906 and the APOE epsilon3 allele improved their LDLc reduction but continued to have a diminished LDLc reduction compared with noncarriers (-30.5+/-4.0% versus -42.0+/-2.4%; P=0.005) and (-38.5+/-1.9% versus -45.3+/-2.8%; P=0.009), respectively. CONCLUSIONS: An intronic single nucleotide polymorphism in ABCA1 and the APOE epsilon3 allele are associated with reduced LDLc lowering by statins and identify individuals who may be resistant to maximal LDLc lowering by statins.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Cardiovasc Genet

DOI

EISSN

1942-3268

Publication Date

December 2008

Volume

1

Issue

2

Start / End Page

100 / 106

Location

United States

Related Subject Headings

  • Simvastatin
  • Regression Analysis
  • Pyrroles
  • Pravastatin
  • Polymorphism, Single Nucleotide
  • Middle Aged
  • Male
  • Hyperlipidemias
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Voora, D., Shah, S. H., Reed, C. R., Zhai, J., Crosslin, D. R., Messer, C., … Ginsburg, G. S. (2008). Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. Circ Cardiovasc Genet, 1(2), 100–106. https://doi.org/10.1161/CIRCGENETICS.108.795013
Voora, Deepak, Svati H. Shah, Carol R. Reed, Jun Zhai, David R. Crosslin, Chad Messer, Benjamin A. Salisbury, and Geoffrey S. Ginsburg. “Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.Circ Cardiovasc Genet 1, no. 2 (December 2008): 100–106. https://doi.org/10.1161/CIRCGENETICS.108.795013.
Voora D, Shah SH, Reed CR, Zhai J, Crosslin DR, Messer C, et al. Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. Circ Cardiovasc Genet. 2008 Dec;1(2):100–6.
Voora, Deepak, et al. “Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.Circ Cardiovasc Genet, vol. 1, no. 2, Dec. 2008, pp. 100–06. Pubmed, doi:10.1161/CIRCGENETICS.108.795013.
Voora D, Shah SH, Reed CR, Zhai J, Crosslin DR, Messer C, Salisbury BA, Ginsburg GS. Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. Circ Cardiovasc Genet. 2008 Dec;1(2):100–106.

Published In

Circ Cardiovasc Genet

DOI

EISSN

1942-3268

Publication Date

December 2008

Volume

1

Issue

2

Start / End Page

100 / 106

Location

United States

Related Subject Headings

  • Simvastatin
  • Regression Analysis
  • Pyrroles
  • Pravastatin
  • Polymorphism, Single Nucleotide
  • Middle Aged
  • Male
  • Hyperlipidemias
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans